Eric G. Mohler, PhD
Affiliations: | AbbVie |
Area:
psychopharmacology; biological psychiatryGoogle:
"Eric Mohler"Mean distance: 14.99 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Christina Williams | grad student | 1996-2002 | Duke | |
| Paul E. Gold | post-doc | UIUC | ||
| Michael E. Ragozzino | post-doc | University of Illinois, Chicago | ||
| Ben Givens | research scientist | Ohio State | ||
| (Undergraduate thesis advisor) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lindner K, Beckenbauer K, van Ek LC, et al. (2022) Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Reports. 38: 110435 |
| Krishnan N, Chen X, Donnelly-Roberts D, et al. (2020) Small Molecule Phenotypic Screen Identifies Novel Regulators of LDLR Expression. Acs Chemical Biology |
| Gardner RS, Newman LA, Mohler EG, et al. (2020) Aging is not equal across memory systems. Neurobiology of Learning and Memory. 172: 107232 |
| Petros AM, Korepanova A, Jakob CG, et al. (2019) Fragment-based Discovery of an ApolipoproteinE4 (apoE4) Stabilizer. Journal of Medicinal Chemistry |
| Ding Z, Brown JW, Rueter LE, et al. (2018) Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test. Psychopharmacology |
| Hudzik TJ, Basso AM, Lynch JJ, et al. (2017) Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR). Pharmacology, Biochemistry, and Behavior |
| Mohler EG, Ding Z, Rueter LE, et al. (2015) Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test. Psychopharmacology |
| Mohler EG, Franklin SR, Rueter LE. (2014) Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats. Psychopharmacology. 231: 67-74 |
| Mohler EG, Baker PM, Gannon KS, et al. (2012) The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats. Psychopharmacology. 220: 687-96 |
| Lenz RA, Baker JD, Locke C, et al. (2012) The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220: 97-107 |